Royal Bank Of Canada Nemaura Medical Inc. Transaction History

Royal Bank Of Canada

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.15 - $0.34 $33 - $75	223 Added 83.21%	491 $0
Q3 2023 Nov 14, 2023	SELL	$0.32 - $1.14 $52 - $186	-164 Reduced 37.96%	268 $0
Q2 2023 Aug 14, 2023	BUY	$0.49 - $0.93 $211 - $401	432 New	432 $0
Q3 2022 Nov 14, 2022	BUY	$1.52 - $2.57 $86 - $146	57 New	57 $0
Q3 2021 Nov 15, 2021	SELL	$5.76 - $9.95 $10,771 - $18,606	-1,870 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$4.7 - $16.7 $8,789 - $31,229	1,870 New	1,870 $19,000

Ticker NMRD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,102,900
Market Cap $723K
Description
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.